In conclusion, our results showed that Ginaton treatment inhibited Ang II-induced M1 phenotype macrophage activation, adhesion and mitigation, and the inflammatory response, leading to impaired and dysfunctional hypertension and cardiac remodeling. This evidence concerns the gene AGT and hypertensive disorder.